Unintended consequences of drug formularies

被引:15
作者
Horn, SD [1 ]
机构
[1] UNIV UTAH,SCH MED,DEPT MED INFORMAT,SALT LAKE CITY,UT
关键词
D O I
10.1093/ajhp/53.18.2204
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:2204 / 2206
页数:3
相关论文
共 7 条
[1]  
COVINGTON TR, 1995, PHARM GUIDE PRINCIPL, pCH4
[2]  
Horn S., 1996, Am. J. Manag. Care, V2, P253
[3]  
Horn S.D., 1996, AM J MANAG CARE, V2, P237
[4]  
LEVY RA, 1996, COMPONENT MANAGEMENT
[5]   HMO formularies and care costs [J].
RossDegnan, D ;
Soumerai, SB .
LANCET, 1996, 347 (9010) :1264-1264
[6]   EFFECTS OF MEDICAID DRUG-PAYMENT LIMITS ON ADMISSION TO HOSPITALS AND NURSING-HOMES [J].
SOUMERAI, SB ;
ROSSDEGNAN, D ;
AVORN, J ;
MCLAUGHLIN, TJ ;
CHOODNOVSKIY, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (15) :1072-1077
[7]   EFFECTS OF LIMITING MEDICAID DRUG-REIMBURSEMENT BENEFITS ON THE USE OF PSYCHOTROPIC AGENTS AND ACUTE MENTAL-HEALTH-SERVICES BY PATIENTS WITH SCHIZOPHRENIA [J].
SOUMERAI, SB ;
MCLAUGHLIN, TJ ;
ROSSDEGNAN, D ;
CASTERIS, CS ;
BOLLINI, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (10) :650-655